Product Information
TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by Major Pharmaceuticals, priced at $0.0888 per GM under NDC 00904880531. Its NADAC has been published 76 times since Apr 23, 2025.
Strength
400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
Manufacturer
Major PharmaceuticalsNDC
00904880531
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
4/20/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC OINTMENT has been published 76 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0888 per GM |
|---|---|
| All-time high | $0.0906 (Jan 14, 2026) |
| All-time low | $0.0800 (Sep 17, 2025) |
| 52-week high | $0.0906 |
| 52-week low | $0.0800 |
| Median price | $0.0880 |
| Average price | $0.0870 |
| Largest weekly change | +4.6% (Dec 17, 2025) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bacitracin Zinc, Neomycin, Polymyxin B Sulfat market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin Zinc, Neomycin, Polymyxin B Sulfat market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC OINTMENT, manufactured by Major Pharmaceuticals, is $0.0888 per GM (NDC 00904880531), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has held within roughly two percent of its current level. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC OINTMENT?
Since Apr 23, 2025, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.0800 (Sep 17, 2025) to a high of $0.0906 (Jan 14, 2026), with a median of $0.0880 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of TRIPLE ANTIBIOTIC OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIPLE ANTIBIOTIC OINTMENT?
TRIPLE ANTIBIOTIC OINTMENT (NDC 00904880531) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.